EichorEICHOR
Study identifier: NCT07679685 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Not Yet Recruiting

Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye

Condition: Dry Eye  ·  Sponsor: Beijing Tongren Hospital

PhasePhase 4
Planned participants159
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This is a prospective, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety of perfluorohexyloctane (PFHO) eye drops (Hengqin®, Chengdu Shengdi Pharmaceutical Co., Ltd.) compared with 0.1% sodium hyaluronate eye drops in patients with video display terminal (VDT)-associated dry eye. Participants aged 18-70 years with mild to moderate dry eye (confirmed by Chinese Dry Eye Expert Consensus 2020 criteria) who use video display terminal for more than 6 hours/day and at least 5 days/week for more than 1 year will be enrolled. A total of 159 subjects will be randomized in a 2:1 ratio to the experimental group (PFHO eye drops, n=106) or control group (0.1% sodium hyaluronate eye drops, n=53), both administered 1 drop/eye, 4 times daily (3-5 hour intervals), bilaterally, for 8 weeks. The primary endpoint is the change from baseline in fluorescein tear film break-up time (FBUT) at Week 8. Secondary endpoints include FBUT changes at Weeks 2 and 4, standard patient evaluation of eye dryness(SPEED) questionnaire score changes, total corneal fluorescein staining (tCFS), partial blink rate (PBR), non-invasive tear film break-up time (NIBUT), lipid layer thickness (LLT), meibomian gland secretion quality score, and This is a prospective, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety of perfluorohexyloctane (PFHO) eye drops (Hengqin®, Chengdu Shengdi Pharmaceutical Co., Ltd.) compared with 0.1%…

This description comes directly from the study's public registry record.

Talk to the study team

Jin Yuan  ·  010-58366699  ·  yuanjincornea@126.com

Always discuss trial participation with your own doctor first.

Locations (9)

Beijing Anzhen HospitalBeijing, Beijing Municipality, China
Beijing Aier-Intech Eye HospitalBeijing, China
Chinese PLA General HospitalBeijing, China
Peking Union Medical College HospitalBeijing, China
Guangdong Provincial People's HospitalGuangzhou, China
Sun Yat-sen Memorial HospitalGuangzhou, China
Eye & ENT Hospital of Fudan UniversityShanghai, China
Xi'an Fourth HospitalXi'an, China
Zhongshan City People's HospitalZhongshan, China

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →